185 related articles for article (PubMed ID: 17286521)
1. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
Nasrallah HA
J Clin Psychiatry; 2007; 68 Suppl 1():3-4. PubMed ID: 17286521
[No Abstract] [Full Text] [Related]
2. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial.
Nasrallah HA
J Clin Psychiatry; 2007; 68 Suppl 1():5-11. PubMed ID: 17286522
[TBL] [Abstract][Full Text] [Related]
3. Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.
Weiden PJ
J Clin Psychiatry; 2007; 68 Suppl 1():12-9. PubMed ID: 17286523
[TBL] [Abstract][Full Text] [Related]
4. Strategies for the long-term treatment of schizophrenia: real-world lessons from the CATIE trial.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 1():28-33. PubMed ID: 17286525
[TBL] [Abstract][Full Text] [Related]
5. Introduction: evaluating clinical trial data from schizophrenia research.
Tamminga CA
J Clin Psychiatry; 2001; 62 Suppl 9():3-4. PubMed ID: 11379829
[No Abstract] [Full Text] [Related]
6. The CATIE study and its implications for antipsychotic drug use.
Janicak PG
Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293
[No Abstract] [Full Text] [Related]
7. The CATIE schizophrenia trial: results, impact, controversy.
Manschreck TC; Boshes RA
Harv Rev Psychiatry; 2007; 15(5):245-58. PubMed ID: 17924259
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations.
Stroup TS; Alves WM; Hamer RM; Lieberman JA
Nat Rev Drug Discov; 2006 Feb; 5(2):133-46. PubMed ID: 16518380
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Antipsychotic Trials of Intervention Effectiveness: what did we learn?
Boyd MA
Arch Psychiatr Nurs; 2008 Feb; 22(1):56-8. PubMed ID: 18207059
[No Abstract] [Full Text] [Related]
10. Antipsychotic safety and efficacy concerns.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic medication adherence in schizophrenia.
Byerly MJ; Nakonezny PA; Lescouflair E
Psychiatr Clin North Am; 2007 Sep; 30(3):437-52. PubMed ID: 17720031
[TBL] [Abstract][Full Text] [Related]
12. The case for long-acting antipsychotic agents in the post-CATIE era.
Nasrallah HA
Acta Psychiatr Scand; 2007 Apr; 115(4):260-7. PubMed ID: 17355516
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of treatment effects in schizophrenia.
Stroup TS
Am J Med; 2007 Apr; 120(4 Suppl 1):S26-31. PubMed ID: 17403379
[TBL] [Abstract][Full Text] [Related]
14. New generation antipsychotic drugs and compliance behaviour.
Voruganti LP; Baker LK; Awad AG
Curr Opin Psychiatry; 2008 Mar; 21(2):133-9. PubMed ID: 18332660
[TBL] [Abstract][Full Text] [Related]
15. Piperacetazine study in state hospital patients.
del Portillo L
J Med Assoc Ga; 1974 Dec; 63(12):465-7. PubMed ID: 4154960
[No Abstract] [Full Text] [Related]
16. Methodological and design issues in clinical trials of new neuroleptics: an overview.
Awad AG
Br J Psychiatry Suppl; 1993 Dec; (22):51-7. PubMed ID: 7906524
[TBL] [Abstract][Full Text] [Related]
17. Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
Leucht S; Kissling W; Davis JM
Psychol Med; 2009 Oct; 39(10):1591-602. PubMed ID: 19335931
[TBL] [Abstract][Full Text] [Related]
18. [CATIE: welcome to the real world].
Alvarez E; Bernardo M; Roca M
Actas Esp Psiquiatr; 2006; 34(4):213-5. PubMed ID: 16823680
[No Abstract] [Full Text] [Related]
19. Interpreting and applying the EUFEST results using number needed to treat: antipsychotic effectiveness in first-episode schizophrenia.
Citrome L
Int J Clin Pract; 2008 May; 62(5):837-40. PubMed ID: 18412940
[No Abstract] [Full Text] [Related]
20. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Heinrichs RW
Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
